We are live on ! Find out more
VHAQ.RT

Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT

Delisted

VHAQ.RT was delisted on the 20th of February, 2024.

28 hedge funds and large institutions have $574K invested in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 2928 (-1)

8% less capital invested

Capital invested by funds: $623K → $574K (-$48.8K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MI
1
MMCAP International
Cayman Islands
$75K
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$69K
OCAM
3
Owl Creek Asset Management
New York
$49.7K
BFM
4
Boothbay Fund Management
New York
$48.1K -$12 -219 -0%
ASM
5
ATW SPAC Management
New York
$48K
CH
6
CVI Holdings
Delaware
$42K
CS
7
Clear Street
New York
$31.6K -$85 -1,500 -0.3%
CAC
8
Cowen and Company
New York
$31.6K +$350 +6,200 +1%
SCM
9
Shaolin Capital Management
Florida
$29.7K -$7.66K -135,481 -22%
BCM
10
Bluefin Capital Management
New York
$24.1K
SOA
11
Sea Otter Advisors
Florida
$22.3K
LA
12
Linden Advisors
New York
$19.5K
NM
13
Newtyn Management
New York
$11.3K
PC
14
Periscope Capital
Ontario, Canada
$10.8K
RCM
15
Rivernorth Capital Management
Florida
$8.58K
GF
16
Gabelli Funds
New York
$7.12K
MP
17
Mangrove Partners
Connecticut
$7.09K
LCM
18
Landscape Capital Management
New Jersey
$6.67K
FTUS
19
Flow Traders U.S.
New York
$5K -$141 -2,501 -2%
HF
20
HRT Financial
New York
$5K -$5 -88 -0.1%
GCIA
21
Gabelli & Co Investment Advisers
New York
$4.99K
Walleye Capital
22
Walleye Capital
New York
$4.92K
RCM
23
Radcliffe Capital Management
Pennsylvania
$3.21K -$14.9K -263,844 -81%
Walleye Trading
24
Walleye Trading
New York
$2.74K
Millennium Management
25
Millennium Management
New York
$2.63K

VHAQ.RT Hedge Fund Activity: Q4 2023 in Review

28 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) for Q4 2023, worth a combined $574K — down 7.8% from $623K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VHAQ.RT and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 2 added.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $554. The largest seller was SkyView Investment Advisors, exiting entirely with an estimated $23K sold.

  • 28 institutional investors held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) as of Q4 2023, down from 29 in Q3 2023.
  • Funds reported $574K of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock stock for Q4 2023, down 7.8% quarter-over-quarter.
  • 1 fund opened new Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock positions in Q4 2023 and 2 closed out, a net change of -1 holder.
  • The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock buyer in Q4 2023 was Schonfeld Strategic Advisors, an estimated $554 added.
  • The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock seller in Q4 2023 was SkyView Investment Advisors, an estimated $23K sold.

Based on aggregated 13F filings for Q4 2023.